WORLDWIDE POST-MARKETING SAFETY SURVEILLANCE EXPERIENCE WITH TOFACITINIB IN ULCERATIVE COLITIS

被引：0
|
作者：
Rubin, David T.
Modesto, Irene
Vermeire, Severine
Danese, Silvio
Ng, Siew C.
Kwok, Kenneth K.
Koram, Nana
Jones, Thomas V.
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
130
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [41] Social Media Listening for Routine Post-Marketing Safety Surveillance
    Gregory E. Powell
    Harry A. Seifert
    Tjark Reblin
    Phil J. Burstein
    James Blowers
    J. Alan Menius
    Jeffery L. Painter
    Michele Thomas
    Carrie E. Pierce
    Harold W. Rodriguez
    John S. Brownstein
    Clark C. Freifeld
    Heidi G. Bell
    Nabarun Dasgupta
    [J]. Drug Safety, 2016, 39 : 443 - 454
  • [42] Efficacy and safety of nateglinide in post-marketing surveillance studies in Japan
    Damholt, BB
    Golor, G
    Wierich, W
    Pedersen, PC
    Ekblom, M
    Zdravkovic, M
    [J]. DIABETES, 2005, 54 : A114 - A114
  • [43] Social Media Listening for Routine Post-Marketing Safety Surveillance
    Powell, Gregory E.
    Seifert, Harry A.
    Reblin, Tjark
    Burstein, Phil J.
    Blowers, James
    Menius, J. Alan
    Painter, Jeffery L.
    Thomas, Michele
    Pierce, Carrie E.
    Rodriguez, Harold W.
    Brownstein, John S.
    Freifeld, Clark C.
    Bell, Heidi G.
    Dasgupta, Nabarun
    [J]. DRUG SAFETY, 2016, 39 (05) : 443 - 454
  • [44] Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance
    Kuwana, Masataka
    Sugiyama, Naonobu
    Momohara, Shigeki
    Atsumi, Tatsuya
    Takei, Syuji
    Tamura, Naoto
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Takeuchi, Tsutomu
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Tanigawa, Miki
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    Mimori, Tsuneyo
    Takagi, Michiaki
    [J]. MODERN RHEUMATOLOGY, 2024, 34 (02) : 272 - 286
  • [45] The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn's Disease: 4 Years of Global Post-marketing Data
    Cohen, Russell D.
    Bhayat, Fatima
    Blake, Aimee
    Travis, Simon
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 (02): : 192 - 204
  • [46] Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
    Nakamura, Shiro
    Asano, Teita
    Tsuchiya, Hiroaki
    Sugimoto, Kanami
    Imai, Yuya
    Yokoyama, Seiji
    Suzuki, Yasuo
    [J]. INTESTINAL RESEARCH, 2022, 20 (03) : 329 - +
  • [47] Ulcerative colitis: efficacy and safety of tofacitinib studied
    Kessing, Richard
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (10):
  • [48] Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis
    McNally, M.
    Keating, E.
    Gray, E.
    McCormick, E.
    Carroll, A.
    Palmer, C.
    Kennedy, U.
    McKiernan, S.
    MacCarthy, F.
    Dunne, C.
    Hartery, K.
    Egan, L.
    Slattery, E.
    Ryan, B.
    McNamara, D.
    O'Connor, A.
    Breslin, N.
    O'Donnell, S.
    Cullen, G.
    Mulcahy, H.
    Sheridan, J.
    Doherty, G.
    Kevans, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I431 - I431
  • [49] Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis
    McNally, M.
    Keating, E.
    Gray, E.
    McCormick, E.
    Carroll, A.
    Palmer, C.
    Kennedy, U.
    McKiernan, S.
    MacCarthy, F.
    Dunne, C.
    Hartery, K.
    Egan, L.
    Slattery, E.
    Ryan, B.
    McNamara, D.
    O'Connor, A.
    Breslin, N.
    O'Donnell, S.
    Cullen, G.
    Mulcahy, H.
    Sheridan, J.
    Doherty, G.
    Kevans, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I431 - I431
  • [50] Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients
    Di Rienzo, V
    Pagani, A
    Parmiani, S
    Passalacqua, G
    Canonica, GW
    [J]. ALLERGY, 1999, 54 (10) : 1110 - 1113
12345